Eli Lilly beats Novo Nordisk to launch diabetes and weight-loss drug Mounjaro in India, at $50 for 5 mg vial
US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...